Early research (Phase 1)Study completedNCT01324479What this trial is testingStudy of INC280 in Patients With c-MET Dependent Advanced Solid TumorsWho this might be right forSolid Tumors Novartis Pharmaceuticals 131
Not applicableLooking for participantsNCT06160596What this trial is testingAnalyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor PrognosisWho this might be right forPancreas AdenocarcinomaSmall-cell Lung CancerGlioblastoma, IDH-wildtype Cure 51 1,020
Very early researchStudy completedNCT01383135What this trial is testingBiodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2Who this might be right forBreast CancerNon-Small-Cell Lung CancerGlioblastoma+1 more Stanford University 27
Not applicableStudy completedNCT01598597What this trial is testingAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)Who this might be right forBreast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more Genentech, Inc. 276
Not applicableLooking for participantsNCT07636200What this trial is testingThe EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced CancerWho this might be right forAdvanced Solid Tumor CancerStage IV Cancer (Solid Tumors Only)Glioblastoma+2 more University of Colorado, Boulder 250
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Ended earlyNCT00112619What this trial is testingTopotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid TumorsWho this might be right forBrain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more Pediatric Brain Tumor Consortium 19
Not applicableLooking for participantsNCT03958240What this trial is testingDeciphering Mechanisms Underlying Cancer ImmunogenicityWho this might be right forHead and Neck CancerOvarian CancerCervical Cancer+4 more Institut Claudius Regaud 1,100
Testing effectiveness (Phase 2)Study completedNCT04444427What this trial is testingEvaluation of GLR2007 for Advanced Solid TumorsWho this might be right forNon-small Cell Lung CancerGlioblastoma Multiforme Gan and Lee Pharmaceuticals, USA 19
Not applicableNot Yet RecruitingNCT07689721What this trial is testingCtDNA-Guided Intraventricular Therapy for CNS MalignanciesWho this might be right forLeptomeningeal DiseaseGlioblastomaBrain Metastases+2 more Alireza Mansouri 77
Testing effectiveness (Phase 2)Looking for participantsNCT03175224What this trial is testingAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsWho this might be right forSolid TumorsAdvanced CancerRenal Cancer+15 more Apollomics Inc. 497
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07604285What this trial is testingSafety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated GlioblastomaWho this might be right forGlioblastoma Myosin Therapeutics Inc. 36
Not applicableLooking for participantsNCT03452774What this trial is testingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryWho this might be right forCancer, MetastaticCancerCancer of Pancreas+40 more Massive Bio, Inc. 50,000
Testing effectiveness (Phase 2)Ended earlyNCT01392352What this trial is testingHYPAZ: Hypertension Induced by PazopanibWho this might be right forRenal Cell CarcinomaSoft Tissue SarcomaGlioblastoma+8 more Cambridge University Hospitals NHS Foundation Trust 31
Testing effectiveness (Phase 2)Looking for participantsNCT06810544What this trial is testingSafety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossWho this might be right forNon Small Cell Lung CancerGlioma Glioblastoma MultiformeGlioma, Malignant+4 more Tango Therapeutics, Inc. 191
Early research (Phase 1)Study completedNCT00363272What this trial is testingIspinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06690216What this trial is testingEvaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant TumorsWho this might be right forGlioblastoma (GBM)Head and Neck Squamous Cell CarcinomaNon-Small Cell Lung Cancer+1 more Man Hu 100